NASDAQ · LMAT

LeMaitre Vascular, Inc.

$95.59 -$1.90 (-1.95%) 1D After hours
Charting by TradingView

Key Metrics

$2.23B
Market cap
35.70×
P/E · TTM
$249.60M
Revenue · TTM
$62.40M
Net income
EPS · TTM $2.73
Dividend yield 0.9%
Free cash flow $79.12M
Beta · 1Y 0.53
EBITDA · TTM $91.10M
Gross margin 74.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 26
    The stock moved +24.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.23B
Enterprise value—
Shares outstanding22.9M
52-wk range$79.01 – $118.01
Avg volume · 20D142.5K
Net cash —
Book value / share$17.76
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About LeMaitre Vascular, Inc.
IPO dateOct 19, 2006
Employees655

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E35.70
P/S8.93
P/FCF28.16
EV/EBITDA—
EV/Sales—
Graham №$33.00

Profitability

Gross 74.3%
Operating 32.3%
Net 25.0%
FCF 31.7%
ROE / ROIC 16.8% · 158.4%

Financial Health

Current ratio14.32
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$444.45M

Cash Flow · TTM

Operating CF $87.31M
Capex −$8.18M
Free cash flow $79.12M
Buybacks $1.68M
Dividends paid $19.30M
Shareholder yield 0.9%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

8.1
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$33.00 vs $95.59
Trades 2.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings